Skip header and navigation

Refine By

17423 records – page 1 of 1743.

Outcomes in smokers and alcohol users after fast-track hip and knee arthroplasty.

https://arctichealth.org/en/permalink/ahliterature116210
Source
Acta Anaesthesiol Scand. 2013 May;57(5):631-8
Publication Type
Article
Date
May-2013
Author
C C Jørgensen
H. Kehlet
Author Affiliation
Section for Surgical Pathophysiology 4074, Rigshospitalet, Copenhagen University, Copenhagen, Denmark. christoffer.calov.joergensen@regionh.dk
Source
Acta Anaesthesiol Scand. 2013 May;57(5):631-8
Date
May-2013
Language
English
Publication Type
Article
Keywords
Age Distribution
Aged
Alcohol Drinking - adverse effects - epidemiology
Arthroplasty, Replacement, Hip - statistics & numerical data
Arthroplasty, Replacement, Knee - statistics & numerical data
Denmark - epidemiology
Female
Follow-Up Studies
Humans
Length of Stay - statistics & numerical data
Male
Middle Aged
Odds Ratio
Postoperative Complications - epidemiology
Prospective Studies
Questionnaires
Recovery of Function
Risk factors
Smoking - adverse effects - epidemiology
Abstract
Smoking and alcohol use impair post-operative outcomes. However, no studies include fast-track surgery, which is a multimodal-enhanced recovery programme demonstrated to improve outcome. We hypothesised that outcome is similar in smokers and alcohol users as in non-users after fast-track hip and knee arthroplasty.
Prospective questionnaires on co-morbidity and smoking/alcohol use were cross-referenced with the Danish National Health Registry to investigate relationship between smoking/alcohol use and length of stay of > 4 days and readmissions = 90 days after fast-track hip and knee arthroplasty.
In 3041 consecutive patients, 458 reported smoking and 216 drinking > 2 drinks a day, of which 66 did both. Smokers/alcohol users were younger than non-users (mean age: 64.3 vs. 68.0 years, P 4 days and smoking (odds ratio [95% confidence interval], P) (1.34 [0.92-1.95], 0.127) or alcohol use (0.59 [0.30-1.16], 0.127). Thirty- and ninety-day readmission rate was 6.6% (n = 201) and 9.4% (n = 285). Multiple logistic regression analysis showed an increased risk of readmissions in smokers at 30 (1.60 [1.05-2.44], 0.028) but not 90-day follow-up (1.17 [0.80-1.73], 0.419). No increased risk of readmissions was found in alcohol users at 30 (0.94 [0.50-1.76], 0.838) or 90-day follow-up (0.83 [0.47-1.49], 0.532). No increased risk of specific readmissions (i.e. wound infections or pneumonia) typically related to smoking/alcohol use was found in smokers (1.56 [0.93-2.62], 0.091) or alcohol users (1.00 [0.47-2.15], 0.999) at 90-day follow-up.
Influence of smoking or alcohol use may be less pronounced in fast-track hip and knee arthroplasty compared with data with conventional care programmes.
PubMed ID
23421518 View in PubMed
Less detail

Prevalence of childhood celiac disease and changes in infant feeding.

https://arctichealth.org/en/permalink/ahliterature116222
Source
Pediatrics. 2013 Mar;131(3):e687-94
Publication Type
Article
Date
Mar-2013

An observational study of venoplasty in patients with multiple sclerosis.

https://arctichealth.org/en/permalink/ahliterature116230
Source
Can J Neurol Sci. 2013 Mar;40(2):203-9
Publication Type
Article
Date
Mar-2013
Author
W. Pryse-Phillips
M. Stefanelli
K. Murphy-Peddle
B. Barrett
Author Affiliation
Department of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. wpryse@mun.ca
Source
Can J Neurol Sci. 2013 Mar;40(2):203-9
Date
Mar-2013
Language
English
Publication Type
Article
Keywords
Angioplasty, Balloon - methods
Canada
Disability Evaluation
Female
Follow-Up Studies
Humans
Magnetic Resonance Imaging
Male
Multiple Sclerosis - therapy
Observation
Phlebography
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Abstract
It is estimated that some hundreds of Canadian patients with multiple sclerosis (MS) have journeyed abroad to avail themselves of 'liberation therapy' (venoplasty) following the initial report by Zamboni et al in 2009. That study also led to public pressure upon Departments of Health in Canadian Provinces to fund the procedure. The present study was done in order to advise the Government of Newfoundland and Labrador as to whether or not it should do so.
We conducted an observational study of 30 MS subjects who had submitted to venoplasty, using objective, semi-objective and subjective measures.
Significant subjective improvement was reported by half of the subjects at three months, although the degree of perceived improvement was less at 12 months. The objective and semi-objective tests employed did not indicate improvement in any area over the one-year follow-up period. Seven of the 29 subjects in whom CT venography was performed at the end of the study year were found to have uni- or bilateral occlusion or >50% stenosis of at least one cervical draining vein, but they showed no deterioration in their clinical status compared to those in whom no venous occlusion nor stenosis was found.
No objective improvement was found at one year in thirty MS subjects who had undergone venoplasty, although many reported a degree of subjective benefit.
Notes
Comment In: Can J Neurol Sci. 2013 Mar;40(2):141-323419560
PubMed ID
23419569 View in PubMed
Less detail

Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.

https://arctichealth.org/en/permalink/ahliterature116236
Source
J Clin Psychiatry. 2013 Jan;74(1):e94-9
Publication Type
Article
Date
Jan-2013
Author
Jussi A Niemi-Pynttäri
Reijo Sund
Hanna Putkonen
Helena Vorma
Kristian Wahlbeck
Sami P Pirkola
Author Affiliation
Department of Psychiatry, Helsinki City Health Centre, Helsinki, Finland. jussi.niemi-pynttari@hel.fi
Source
J Clin Psychiatry. 2013 Jan;74(1):e94-9
Date
Jan-2013
Language
English
Publication Type
Article
Keywords
Adult
Alcohol-Induced Disorders - diagnosis - epidemiology - psychology
Amphetamines - adverse effects
Cannabinoids - adverse effects
Cross-Sectional Studies
Diagnostic and Statistical Manual of Mental Disorders
Ethanol - adverse effects
Female
Finland
Follow-Up Studies
Humans
International Classification of Diseases
Male
Middle Aged
Patient Discharge
Psychoses, Substance-Induced - diagnosis - epidemiology - psychology
Registries
Schizophrenia - chemically induced - diagnosis - epidemiology
Schizophrenic Psychology
Abstract
Despite the clinical importance of substance-induced psychosis (SIP), few studies have examined the course of this condition after its acute manifestation.
To investigate the rate of SIP conversion to a schizophrenia spectrum disorder and the length of follow-up needed to catch the majority of these patients whose diagnoses change. In addition to the conversion rate and pattern, we wanted to look for possible related factors.
Using the nationwide Finnish Hospital Discharge Register, we followed all patients (N = 18,478) since their first inpatient hospital admission with a diagnosis of SIP (codes 2921 and 2928 in DSM-III-R and codes F10-F19 in ICD-10 with a third digit of 4, 5, or 7) between January 1987 and December 2003 in Finland. Patients (mean age = 43.7 years, standard deviation = 13.5 years) were followed until first occurrence of schizophrenia spectrum disorder, death, or the end of December 2003, whichever took place first. Conversions of discharge diagnoses into schizophrenia spectrum disorders (codes 2951-2959 and 2971 in DSM-III-R and codes F20, F22, and F23 in ICD-10) were recorded at follow-up.
Eight-year cumulative risk to receive a schizophrenia spectrum diagnosis was 46% (95% CI, 35%-57%) for persons with a diagnosis of cannabis-induced psychosis and 30% (95% CI, 14%-46%) for those with an amphetamine-induced psychosis. Although alcohol-induced psychosis was the most common type of SIP, 8-year cumulative risk for subsequent schizophrenia spectrum diagnosis was only 5.0% (95% CI, 4.6%-5.5%). No differences were detected with regard to gender, except for amphetamine-induced psychosis, which converted into a schizophrenia spectrum disorder significantly more often in men (P = .04). The majority of conversions to a schizophrenia spectrum diagnosis occurred during the first 3 years following the index treatment period, especially for cannabis-induced psychosis.
Substance-induced psychotic disorders predict schizophrenia spectrum disorders to a greater extent than previously thought. The intensity of clinical attention focused on substance-induced psychotic disorders should be increased.
Notes
Comment In: Evid Based Ment Health. 2013 Aug;16(3):6523708315
PubMed ID
23419236 View in PubMed
Less detail

Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey.

https://arctichealth.org/en/permalink/ahliterature116237
Source
J Clin Psychiatry. 2013 Jan;74(1):e87-93
Publication Type
Article
Date
Jan-2013
Author
Michael B Lensing
Pål Zeiner
Leiv Sandvik
Stein Opjordsmoen
Author Affiliation
Women and Children's Division, Oslo University Hospital, Norway. miclen@ous-hf.no
Source
J Clin Psychiatry. 2013 Jan;74(1):e87-93
Date
Jan-2013
Language
English
Publication Type
Article
Keywords
Adult
Attention Deficit Disorder with Hyperactivity - diagnosis - drug therapy - psychology
Central Nervous System Stimulants - adverse effects - therapeutic use
Delayed-Action Preparations
Dextroamphetamine - adverse effects - therapeutic use
Female
Follow-Up Studies
Humans
Male
Medication Adherence
Methylphenidate - adverse effects - therapeutic use
Norway
Prognosis
Propylamines - adverse effects - therapeutic use
Questionnaires
Treatment Outcome
Abstract
In adults with attention-deficit/hyperactivity disorder (ADHD), pharmacotherapy is a recommended treatment option. However, research on long-term outcome with such treatment has been scarce.
A questionnaire survey was completed by adults with ADHD, diagnosed according to ICD-10/DSM-IV criteria and approved for pharmacotherapy during 2003 to 2005, living in southeastern Norway. The questionnaire was conducted from November 2008 to April 2009. Of an eligible number of 1,096 subjects, 1,080 remained at follow-up; 371 subjects (34.4%) agreed to participate, and 368 of these reported having ever been treated with ADHD medication. Baseline characteristics and self-reported outcome were studied by time on psychopharmacologic treatment. Primary outcome measures were the Adult ADHD Self-Report Scale version 1.1 (ASRS) Screener and the Mental Health Index-5 (MHI-5). Based on cutoff scores for these instruments, 2 groups (favorable outcome vs others) were created to study possible predictors of outcome status.
Self-reported baseline ADHD symptoms and impairment did not differ between participants and nonparticipants. Mean observation time was 4.5 years (range, 3.5-6.0 years). At follow-up, mean age was 36.5 years. Altogether, 270 patients (73.4%) had been treated for more than 24 months. They reported better outcome on all measures compared to those treated for 24 months or less (mean values: ASRS Screener score: 12.8 vs 15.3; MHI-5 score: 63.7 vs 57. 7). The favorable outcome group consisted of 79 participants (21.5%). Comorbidity at baseline predicted poorer outcome than did no comorbid illness.
In adults with ADHD, pharmacologic treatment for more than 2 years was associated with better functioning than treatment for 2 years or less. Comorbidity at baseline predicted poorer outcome.
PubMed ID
23419235 View in PubMed
Less detail

Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study.

https://arctichealth.org/en/permalink/ahliterature116241
Source
Acta Obstet Gynecol Scand. 2013 Jul;92(7):852-7
Publication Type
Article
Date
Jul-2013
Author
Sidsel S Barken
Elsebeth Lynge
Erik S Andersen
Matejka Rebolj
Author Affiliation
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Source
Acta Obstet Gynecol Scand. 2013 Jul;92(7):852-7
Date
Jul-2013
Language
English
Publication Type
Article
Keywords
Adult
Cervical Intraepithelial Neoplasia - diagnosis - surgery
Cervix Uteri - surgery
Conization
Denmark
Early Detection of Cancer - statistics & numerical data
Female
Follow-Up Studies
Humans
Logistic Models
Middle Aged
Odds Ratio
Patient Compliance - statistics & numerical data
Prospective Studies
Registries
Uterine Cervical Neoplasms - diagnosis - surgery
Vaginal Smears - statistics & numerical data
Abstract
To measure adherence to annual follow-up among women treated for cervical intraepithelial neoplasia.
Prospective, population-based, register study.
Denmark, 1996-2007.
All women treated for cervical intraepithelial neoplasia with conization.
Treated women were routinely recommended to have follow-up with annual smears for at least 5 years.
Using individually linked nationwide register data on conizations and follow-up tests (smears and biopsies), we calculated the cumulative proportion of treated women undergoing the recommended follow-up. We measured this cumulative proportion conservatively in 15-month intervals for 5 years.
Adherence to annual follow-up among 45,984 treated women decreased gradually. In total, 90% of these women obtained at least one smear in the first post-treatment year, but only 40% obtained the recommended tests for 5 years. Five-year adherence was substantially better outside the capital area, for example, the odds ratio for women from Jutland compared with women from the capital area was 1.70 (95% confidence interval 1.60-1.82).
Adherence to follow-up after conization was poor in Denmark. Our findings suggest that because of this poor adherence, recommendations for long-term annual follow-up after treatment of cervical intraepithelial neoplasia may not be highly effective. Shorter follow-up schedules using highly sensitive tests appear attractive.
PubMed ID
23418941 View in PubMed
Less detail

Poststroke dementia is associated with recurrent ischaemic stroke.

https://arctichealth.org/en/permalink/ahliterature116255
Source
J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):722-6
Publication Type
Article
Date
Jul-2013
Author
Gerli Sibolt
Sami Curtze
Susanna Melkas
Jukka Putaala
Tarja Pohjasvaara
Markku Kaste
Pekka J Karhunen
Niku K J Oksala
Timo Erkinjuntti
Author Affiliation
Department of Neurology, Helsinki University Central Hospital, P.O. Box 340 (Haartmaninkatu 4), , Helsinki 00029 HUS, Finland. gerli.sibolt@hus.fi
Source
J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):722-6
Date
Jul-2013
Language
English
Publication Type
Article
Keywords
Aged
Aged, 80 and over
Brain Ischemia - complications - epidemiology
Cardiovascular Diseases - complications - epidemiology
Cognition Disorders - etiology - psychology
Cohort Studies
Dementia - epidemiology - etiology
Diagnostic and Statistical Manual of Mental Disorders
Educational Status
Female
Finland - epidemiology
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Magnetic Resonance Imaging
Male
Memory - physiology
Middle Aged
Neuroimaging
Neuropsychological Tests
Recurrence
Regression Analysis
Risk factors
Stroke - complications - epidemiology - etiology
Tomography, X-Ray Computed
Abstract
To investigate whether poststroke dementia (PSD) diagnosed after ischaemic stroke predicts recurrent ischaemic stroke in long-term follow-up.
We included 486 consecutive patients with ischaemic stroke (388 with first-ever stroke) admitted to Helsinki University Central Hospital who were followed-up for 12 years. Dementia was diagnosed in 115 patients using the Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III) criteria. The effects of risk factors and  PSD on survival free of recurrent stroke were estimated using Kaplan-Meier log-rank analyses, and the HRs for stroke recurrence were calculated using Cox proportional hazards models.
In the entire cohort, patients with PSD had a shorter mean time to recurrent stroke (7.13 years, 95% CI 6.20 to 8.06) than patients without dementia (9.41 years, 8.89 to 9.92; log rank p
PubMed ID
23418214 View in PubMed
Less detail

Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.

https://arctichealth.org/en/permalink/ahliterature116274
Source
Urol Oncol. 2013 Oct;31(7):1161-5
Publication Type
Article
Date
Oct-2013
Author
Andrew K Williams
Wassim Kassouf
Joseph Chin
Ricardo Rendon
Niels Jacobsen
Adrian Fairey
Anil Kapoor
Peter Black
Louis Lacombe
Simon Tanguay
Alan So
Jean-Baptiste Lattouf
David Bell
Yves Fradet
Fred Saad
Ed Matsumoto
Darrel Drachenberg
Ilias Cagiannos
Jonathan I Izawa
Author Affiliation
Division of Urology, Department of Surgery and Oncology, UWO, London, Ontario, Canada.
Source
Urol Oncol. 2013 Oct;31(7):1161-5
Date
Oct-2013
Language
English
Publication Type
Article
Keywords
Aged
Canada
Carcinoma, Transitional Cell - pathology - surgery
Databases, Factual
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Kidney Neoplasms - pathology - surgery
Kidney Pelvis - pathology - surgery
Male
Multivariate Analysis
Nephrectomy
Prognosis
Retrospective Studies
Treatment Outcome
Ureter - pathology - surgery
Ureteral Neoplasms - pathology - surgery
Urologic Neoplasms - pathology - surgery
Abstract
Whether a patient has urothelial carcinoma located within the renal pelvis or ureter remains a controversial prognostic indicator in clinical urology. We wished to evaluate whether tumor location is associated with recurrence in patients undergoing nephroureterectomy for upper tract urothelial cancer in a large volume patient cohort.
We created a retrospective database of patients from 7 academic centers throughout Canada who underwent nephroureterectomy for upper tract urothelial carcinoma. Patient demographics as well as pathologic and surgical factors were analyzed to evaluate any statistical association between tumor location and overall survival, disease-free survival, and disease-specific survival.
A total of 1,029 patients had data available for analysis with a mean follow up of 3.2 years. Kaplan Meier 5-year disease-free survivals (DFS) were 46%, 37%, and 19% for renal pelvis tumors, ureteric tumors, and multifocal tumors respectively. There was no association between the location of the tumor and the DFS, however, disease involving both the ureter and renal pelvis was associated with lower DFS and overall survival (OS) (P
PubMed ID
23415596 View in PubMed
Less detail

Does binge drinking during early pregnancy increase the risk of psychomotor deficits?

https://arctichealth.org/en/permalink/ahliterature116287
Source
Alcohol Clin Exp Res. 2013 Jul;37(7):1204-12
Publication Type
Article
Date
Jul-2013
Author
Ulrik Schiøler Kesmodel
Bjørn Bay
Theresa Wimberley
Hanne-Lise F Eriksen
Erik Lykke Mortensen
Author Affiliation
Department of Obstetrics and Gynaecology (USK), Aarhus University Hospital, Aarhus, Denmark. ukes@soci.au.dk
Source
Alcohol Clin Exp Res. 2013 Jul;37(7):1204-12
Date
Jul-2013
Language
English
Publication Type
Article
Keywords
Adult
Alcohol Drinking - adverse effects - epidemiology - physiopathology
Binge Drinking - epidemiology - physiopathology
Child, Preschool
Denmark - epidemiology
Female
Follow-Up Studies
Humans
Male
Pregnancy
Pregnancy Trimester, First - drug effects - physiology
Prenatal Exposure Delayed Effects - epidemiology - physiopathology
Prospective Studies
Psychomotor Disorders - epidemiology - physiopathology
Risk factors
Abstract
The potential effects of binge drinking during pregnancy on child motor function have only been assessed in a few, small studies. We aimed to examine the effects of binge alcohol consumption during early pregnancy, including number of binge episodes and timing of binge drinking, on child motor function at age 5.
We performed a prospective follow-up study of 678 women and their children sampled from the Danish National Birth Cohort based on maternal alcohol consumption during pregnancy. At 5 years of age, the children were tested with the Movement Assessment Battery for Children. Parental education, maternal IQ, prenatal maternal smoking, the child's age at testing, sex of child, and tester were considered core confounders, while the full model also controlled for prenatal maternal average alcohol intake, maternal age and prepregnancy body mass index, parity, home environment, postnatal parental smoking, health status, participation in organized sport, and indicators for hearing and vision impairment.
There were no systematic or significant differences in motor function between children of mothers reporting isolated episodes of binge drinking and children of mothers with no binge episodes. No association was observed with respect to the number of binge episodes (maximum of 12) and timing of binge drinking.
In this study, we found no systematic association between isolated episodes of binge drinking during early pregnancy and child motor function at age 5.
PubMed ID
23414523 View in PubMed
Less detail

Health-related quality of life in adolescents with screening-detected celiac disease, before and one year after diagnosis and initiation of gluten-free diet, a prospective nested case-referent study.

https://arctichealth.org/en/permalink/ahliterature116289
Source
BMC Public Health. 2013;13:142
Publication Type
Article
Date
2013
Author
Katrina Nordyke
Fredrik Norström
Lars Lindholm
Hans Stenlund
Anna Rosén
Anneli Ivarsson
Author Affiliation
Department of Public Health and Clinical Medicine, Epidemiology and Global Health, Umeå University, Umeå, Sweden. katrina.nordyke@epiph.umu.se
Source
BMC Public Health. 2013;13:142
Date
2013
Language
English
Publication Type
Article
Keywords
Adolescent
Case-Control Studies
Celiac Disease - diagnosis - diet therapy
Child
Diet, Gluten-Free
Female
Follow-Up Studies
Health status
Humans
Male
Mass Screening
Prospective Studies
Quality of Life
Questionnaires
Sweden
Time Factors
Treatment Outcome
Abstract
Celiac disease (CD) is a chronic disorder in genetically predisposed individuals in which a small intestinal immune-mediated enteropathy is precipitated by dietary gluten. It can be difficult to diagnose because signs and symptoms may be absent, subtle, or not recognized as CD related and therefore not prompt testing within routine clinical practice. Thus, most people with CD are undiagnosed and a public health intervention, which involves screening the general population, is an option to find those with unrecognized CD. However, how these screening-detected individuals experience the diagnosis and treatment (gluten-free diet) is not fully understood. The aim of this study is to investigate the health-related quality of life (HRQoL) of adolescents with screening-detected CD before and one year after diagnosis and treatment.
A prospective nested case-referent study was done involving Swedish adolescents who had participated in a CD screening study when they were in the sixth grade and about 12?years old. Screening-detected adolescents (n?=?103) and referents without CD who participated in the same screening (n?=?483) answered questionnaires at the time of the screening and approximately one year after the screening-detected adolescents had received their diagnosis that included the EQ-5D instrument used to measure health status and report HRQoL.
The HRQoL for the adolescents with screening-detected CD is similar to the referents, both before and one year after diagnosis and initiation of the gluten-free diet, except in the dimension of pain at follow-up. In the pain dimension at follow-up, fewer cases reported problems than referents (12.6% and 21.9% respectively, Adjusted OR 0.50, 95% CI 0.27-0.94). However, a sex stratified analysis revealed that the significant difference was for boys at follow-up, where fewer screening-detected boys reported problems (4.3%) compared to referent boys (18.8%) (Adjusted OR 0.17, 95% CI 0.04-0.73).
The findings of this study suggest that adolescents with unrecognized CD experience similar HRQoL as their peers without CD, both before and one year after diagnosis and initiation of gluten-free diet, except for boys in the dimension of pain at follow-up.
Notes
Cites: Aliment Pharmacol Ther. 2005 Aug 15;22(4):317-2416097998
Cites: Acta Paediatr. 1993 Mar;82(3):235-88495075
Cites: Aliment Pharmacol Ther. 2007 Nov 1;26(9):1217-2517944736
Cites: World J Gastroenterol. 2008 Jan 7;14(1):46-5218176960
Cites: Clin Gastroenterol Hepatol. 2008 Sep;6(9):983-718585974
Cites: Dig Liver Dis. 2009 Jan;41(1):15-2518602354
Cites: Pediatrics. 2009 Apr;123(4):e582-819336349
Cites: Aliment Pharmacol Ther. 2009 May 15;29(10):1131-619245681
Cites: Gastroenterology. 2009 Jul;137(1):88-9319362553
Cites: J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):170-619516192
Cites: Scand J Caring Sci. 2009 Jun;23(2):342-5219645808
Cites: Scand J Gastroenterol. 1998 Sep;33(9):933-89759948
Cites: J Intern Med. 1999 Jan;245(1):63-810095818
Cites: Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1281-615618833
Cites: Gastroenterology. 2005 Apr;128(4 Suppl 1):S74-815825130
Cites: Best Pract Res Clin Gastroenterol. 2005 Jun;19(3):441-5215925848
Cites: BMJ. 2009;339:b359219762413
Cites: BMC Health Serv Res. 2010;10:10520423498
Cites: Qual Life Res. 2010 Aug;19(6):887-9720401552
Cites: Digestion. 2010;82(4):221-820588037
Cites: Clin Gastroenterol Hepatol. 2011 Feb;9(2):118-2321029791
Cites: Eur J Public Health. 2011 Apr;21(2):171-720430804
Cites: Eur J Public Health. 2011 Apr;21(2):178-8320430806
Cites: BMC Pediatr. 2011;11:3221569235
Cites: BMC Gastroenterol. 2011;11:11822060243
Cites: J Med Screen. 2011;18(4):187-9222106434
Cites: Qual Life Res. 2012 Feb;21(1):77-8521598063
Cites: Semin Immunopathol. 2012 Jul;34(4):479-9622549889
Cites: Dig Liver Dis. 2012 Oct;44(10):814-822673312
Cites: Am J Gastroenterol. 2012 Oct;107(10):1538-44; quiz 1537, 154522850429
Cites: Gut. 2013 Jan;62(1):43-5222345659
Cites: Soc Sci Med. 2000 May;50(10):1385-40110741575
Cites: J Pediatr. 2001 Apr;138(4):593-511295729
Cites: BMJ. 2001 Nov 3;323(7320):1061-311691769
Cites: Eff Clin Pract. 2002 May-Jun;5(3):105-1312088289
Cites: Arch Intern Med. 2003 Feb 10;163(3):286-9212578508
Cites: Scand J Caring Sci. 2003 Sep;17(3):301-712919466
Cites: Eur J Epidemiol. 2003;18(7):677-8412952142
Cites: J Am Diet Assoc. 2003 Nov;103(11):1533-514576723
Cites: Dig Dis Sci. 2003 Nov;48(11):2216-2014705832
Cites: Pediatrics. 2007 Apr;119(4):e966-7517403834
PubMed ID
23414483 View in PubMed
Less detail

17423 records – page 1 of 1743.